Skip to search formSkip to main contentSkip to account menu

Doxazosin Mesylate

Known as: 1 (4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazine, Doxazosin Mesylate [Chemical/Ingredient], Mesylate, Doxazosin 
The mesylate salt form of doxazosin, a quinazoline compound with smooth muscle relaxing activity. Doxazosin mesylate selectively antagonizes alpha-1… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2002
Highly Cited
2002
BACKGROUND The African American Study of Kidney Disease and Hypertension (AASK) is an ongoing trial to evaluate the effect of… 
2000
2000
Background: The α1–blocker doxazosin mesylate is an established efficacious and welltolerated treatment for benign prostatic… 
Highly Cited
1999
Highly Cited
1999
AIMS A controlled-release gastrointestinal therapeutic system (GITS) formulation of doxazosin mesylate, a long-acting selective… 
Highly Cited
1997
Highly Cited
1997
OBJECTIVES To compare 5 antihypertensive drugs and placebo for changes in quality of life (QL). To assess the relationship of… 
Highly Cited
1995
Highly Cited
1995
BACKGROUND Increased left ventricular mass (LVM) by echocardiography is associated with increased risk of cardiovascular disease… 
Highly Cited
1993
Highly Cited
1993
Objective. —To compare six antihypertensive interventions for the treatment of mild hypertension. Design. —Randomized, double… 
Highly Cited
1993
Highly Cited
1993
OBJECTIVE To compare six antihypertensive interventions for the treatment of mild hypertension. DESIGN Randomized, double-blind… 
Highly Cited
1993
Highly Cited
1993
To the Editor. —The Treatment of Mild Hypertension Study (TOMHS) 1 represents a worthy contribution to the evaluation of…